A cancer treatment has reached a remarkable milestone.
While Chimeric Antigen Receptor (CAR) T-cell therapy has shown promising effects on blood cancers, like particular types of leukemia or lymphoma, its effects are limited when treating solid tumors — until now.
A 3-year-old boy battling chemo-resistant cancer that had spread from his liver to his lungs and possibly his bones was declared cancer-free after just two doses of the experimental therapy.
The report sharing the progress researchers at Texas Children’s, Baylor College of Medicine and Seattle Children’s was published this month in The New England Journal of Medicine.
The toddler had…
Read the full article at NYPOST.COM
